VOYA Investment Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

VOYA Investment Management’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-20,180	Closed	-$29K	–	2660
2016 Q1	$29K	Hold	20,180	–	–	﹤0.01%	2496
2015 Q4	$65K	Hold	20,180	–	–	﹤0.01%	2527
2015 Q3	$126K	Sell	20,180 -7,466	-27%	-$69.8K	﹤0.01%	2435
2015 Q2	$275K	Hold	27,646	–	–	﹤0.01%	2314
2015 Q1	$204K	Hold	27,646	–	–	﹤0.01%	2421
2014 Q4	$148K	Hold	27,646	–	–	﹤0.01%	2541
2014 Q3	$139K	Hold	27,646	–	–	﹤0.01%	2572
2014 Q2	$186K	Buy	+27,646	New	+$176K	﹤0.01%	2583

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VOYA Investment Management's NWBO Position: Q2 2016 in Review

VOYA Investment Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2016, closing a stake of 20,180 shares — an estimated $29K sold.

VOYA Investment Management first reported a position in NWBO in Q2 2014 and held it in 8 quarters. The position peaked at $275K in Q2 2015. 64 funds tracked by Wall St. Rank hold NWBO as of Q2 2016.

VOYA Investment Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2016 after selling out during the quarter.
VOYA Investment Management sold 20,180 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2016, an estimated $29K.
VOYA Investment Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 8 quarters.
VOYA Investment Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $275K in Q2 2015.
64 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2016.

Based on VOYA Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.